Brief: Eqt Life Sciences' Imcheck Therapeutics To Be Acquired By Ipsen
Oct 22 (Reuters) - EQT AB EQTAB.ST: EQT LIFE SCIENCES' IMCHECK THERAPEUTICS TO BE ACQUIRED BY IPSEN IN A TRANSACTION VALUED AT UP TO EUR 1 BILLION IMCHECK SHAREHOLDERS TO RECEIVE EUR 350 MILLION, TOTAL UP TO EUR 1 BILLION DEAL EXPECTED TO CLOSE BY END OF Q1 2026 Source text: ID:nWkrbPWzwC Further company coverage: EQTAB.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Ipsen SA
See all newsHealth Rounds: New blood test matches gold standard for liver disease diagnosis
Brief: Ipsen Late-Breaking Data Raises Ambitions In PBC
Brief: Charles River Laboratories International Virtual Control Group To Be Used In Glp Study For Ipsen
Pharming shares rise after preliminary Q3 revenue beat
France's Ipsen Q3 sales rise 28% driven by core portfolio